Introduction {#Sec1}
============

Mycotoxins are secondary fungal metabolites which are found in a broad range of food and feed, such as cereals, spices, coffee, nuts or dried fruits \[[@CR1]\]. They have the capability of causing acute toxic, carcinogenic, mutagenic, teratogenic, immunotoxic or oestrogenic effects in animals and humans \[[@CR2]\]. Mycotoxins show a huge structural diversity resulting in a variety of chemical and physicochemical properties. The most important mycotoxins in food and feed, which are regulated in the European Union \[[@CR3]\], are aflatoxins (AFB~1~, AFB~2~, AFG~1~, AFG~2~); ochratoxin A (OTA); type A and B trichothecenes (e.g. HT-2 toxin, T-2 toxin and deoxynivalenol (DON)); fumonisins; and zearalenone.

During the last years, single analyte methods for the detection and quantification of mycotoxins are more and more replaced by multi-target methods for the simultaneous determination of different yet co-occurring classes of mycotoxins. The majority of these methods are based on the combination of high- or ultra-high-performance liquid chromatography with tandem (e.g. \[[@CR4]--[@CR7]\]) or high-resolution \[[@CR8]\] mass spectrometry. The importance of mass spectrometry for the confirmation of mycotoxin identity is emphasised, e.g. in \[[@CR1]\]. A major advantage of LC-MS-based multi-target methods is the increased sample throughput compared to single-analyte methods. Still, such multi-target methods have to cope with huge differences in the relevant toxin concentrations. Naturally, the choice of an appropriate extraction solvent for a large number of analytes with different physicochemical properties is also a great challenge. Mixtures of water with high amounts of methanol or acetonitrile (\>75 %) are appropriate extraction solvents for most mycotoxins. However, for fumonisins, higher extraction recoveries are achieved when the water proportion is increased and/or the pH of the solvent is decreased \[[@CR4]\]. Mol et al. \[[@CR9]\] concluded that aqueous acetone is the favourite extraction solvent with respect to extraction recovery, but aqueous acetonitrile should be preferred considering matrix effects. Extractions using aqueous methanol resulted in extracts exhibiting both lower extraction recoveries and causing more severe matrix effects \[[@CR9]\]. Anyway, the chosen solvent has to be a compromise to reach agreeable extraction recoveries for the majority of the analytes.

Regarding cleanup, multi-target methods use simple "dilute-and-shoot" approaches \[[@CR4], [@CR5], [@CR7], [@CR10]\], solid phase extraction \[[@CR6], [@CR11], [@CR12]\], MycoSep® columns \[[@CR13]\], immunoaffinity columns \[[@CR14]\] and, recently, also QuEChERS \[[@CR8], [@CR15], [@CR16]\]. A drawback of most multi-target methods is that they require extensive validation which is time- and cost-consuming and, hence, often reduced to a minimum. Therefore, these methods are often used just for semiquantitative screening purposes. Most multi-target methods were developed for the measurement of raw cereals, whereas data on the performance characteristics in other matrices like nuts are scarce.

Nuts are hard-shelled fruits of some plants having an indehiscent seed and are an important source of nutrients for humans and animals. Almonds, hazelnuts and pistachios belong to the most popular tree nuts \[[@CR17]\]. More correctly, almonds are not nuts, but drupes which consist of a hull and a hard shell containing the seed. Peanuts or groundnuts are actually legumes, but in the general linguistic usage, they are referred to as nuts. For simplification, the term "nut" will be used in this paper for all four matrices under investigation (almonds, hazelnuts, peanuts and pistachios).

Fungi of the genera *Fusarium*, *Alternaria* and *Cladosporium* dominate the mycobiota of nuts in the field, whilst in storage, *Aspergillus*, *Penicillium* and *Trichoderma* are predominant \[[@CR18]\]. Almost all *Aspergillus parasiticus* strains tested in tree nuts produced aflatoxins, whilst all of the detected *Aspergillus alliaceus* strains produced OTA \[[@CR19]\]. In general, nuts with thick shells (e.g. macadamia nuts) are better protected against the intrusion of moulds. Other nuts, like pistachios, are more prone to mould infestation due to shell splitting at the end of maturation \[[@CR20]\]. Sorting and elimination of split nuts can decrease the contamination of mycotoxins in the lot significantly \[[@CR21]\]. Information about mycotoxin contamination of nuts other than aflatoxins (recently reviewed in \[[@CR22]\]) and OTA is limited. In most cases, only single (OTA) \[[@CR23]\] or group-target (aflatoxins) \[[@CR24]\] methods using chromatographic (TLC, LC-FLD or LC-MS/MS) or immuno-based methods (ELISA, fluorescence immunoassays) were applied for the investigation of the content of those mycotoxins. In 2008, Spanjer et al. \[[@CR5]\] published the validation of an LC-MS/MS-based multi-target method for the determination of mycotoxins in various matrices, including peanuts (13 mycotoxins) and pistachios (24 mycotoxins). A first application for a semiquantitative screening of multiple mycotoxins in various food (including six nut samples) was published in 2010 \[[@CR25]\]. Other studies investigated the occurrence of mycotoxins in peanut cake \[[@CR26], [@CR27]\] and peanuts \[[@CR28]\] from Africa.

Based on previous HPLC-MS/MS methods for the multiple determination of mycotoxins in cereals developed in our group \[[@CR4], [@CR7]\], we created a new multi-target ultra-high-performance liquid chromatographic tandem mass spectrometric (UHPLC-MS/MS) method which covers a total number of 191 fungal metabolites. Validation parameters were obtained for those analytes which seem to be of importance in almonds, hazelnuts, peanuts and pistachios. Finally, we show the applicability of the method by analysing nuts bought on Austrian and Turkish markets.

Experimental {#Sec2}
============

Chemicals, standards and samples {#Sec3}
--------------------------------

Methanol and acetonitrile (both LC gradient grade), as well as acetic acid (p.a.), were purchased from VWR International (Vienna, Austria), whereas ammonium acetate (MS grade) was obtained from Sigma-Aldrich (Vienna, Austria). Water was purified by reverse osmosis followed by a Milli-Q Plus system from Millipore (Molsheim, France).

Solid standards or stock solutions were collected from different sources over the years: They were either isolated by our own group, provided by other research groups or purchased from one of the following commercial companies: Alexis Austria (Vienna, Austria), Alfarma (Prague, Czech Republic), Axxora Europe (Lausanne, Switzerland), Bioaustralis (distributed by Tebu-Bio, Germany), Iris Biotech GmbH (Marktredwitz, Germany), LGC Promochem GmbH (Wesel, Germany), Romer Labs (Tulln, Austria) and Sigma-Aldrich. Individual stock solutions of the standards were prepared by dissolving the weighted solid substance in acetonitrile, or, if insoluble, either in methanol, acetonitrile/water (50:50, *v*/*v*), methanol/water (50:50, *v*/*v*) or pure water. The stock solutions were combined to 30 working solutions containing up to 13 individual mycotoxins and were stored at −20 °C. Before usage, the working solutions were brought to room temperature in the dark, thoroughly mixed and a multi-analyte stock solution was freshly prepared thereof. Neat standard solutions covering a concentration range of three orders of magnitude were obtained by dilution of the multi-analyte stock solution with dilution solvent (acetonitrile/water/acetic acid, 20:79:1, *v*/*v*/*v*) resulting in relative concentrations of 1:3.33:10:33.3:100:333:1,000.

Nut samples were purchased from various stores in Tulln and Vienna (both Austria) or were kindly provided by Dr. Ahmet D. Duman from the Department of Food Engineering of the Faculty of Agriculture of Kahramanmaras Sutcu Imam University (KSU), Turkey. Samples obtained in Austria were stored at −20 °C on the same or following day until usage. Turkish samples were collected on markets, orchards and in warehouses from the Black Sea Region (hazelnuts) or from the Osmaniye province (peanuts) in the harvest season of 2007. Turkish samples were frozen at −20 °C, sent cooled to the IFA-Tulln on the day of purchase and stored until measurement at −20 °C.

Sample preparation {#Sec4}
------------------

Sample preparation was based on the method for cereals described by Sulyok et al. \[[@CR4]\]. In-shell pistachios were pealed and nut samples were ground using an Osterizer® Blender (Sunbeam Oster Household Products, USA). Of the ground samples, 5.00 ± 0.01 g was weighted in 50-mL polypropylene tubes (Sarstedt, Wr. Neudorf, Austria). For extraction, 20 mL extraction solvent (acetonitrile/water/acetic acid, 79:20:1, *v*/*v*/*v*) was added and the samples were extracted in a vertical position on a GFL3017 rotary shaker (Burgwedel, Germany) for 90 min at room temperature (200 rpm). After extraction, the solid residue was allowed to settle for a few minutes. An aliquot of the raw extract was transferred to an HPLC vial and diluted with the same volume of an acetonitrile/water/acetic acid mixture (20:79:1, *v*/*v*/*v*), resulting in a total dilution factor of 8. Five microlitres of this solution was injected into the UHPLC-MS/MS system without any further cleanup.

UHPLC-MS/MS parameters {#Sec5}
----------------------

For the analysis, a 1290 Infinity ultra-high-performance liquid chromatography (UHPLC) system coupled to a 6460 Triple Quadrupole mass spectrometer (both Agilent Technologies, Waldbronn, Germany) was used. Chromatographic separation was performed at 25 °C and a flow rate of 250 μL min^−1^ using a ZORBAX Eclipse Plus C18 Rapid Resolution High Definition (150 × 2.1 mm, 1.8 μm) column from Agilent Technologies. Eluent composition was chosen according to Sulyok et al. \[[@CR4]\], and the gradient was modified to enhance the separation of the analytes. Hence, the eluents were composed of methanol/water/acetic acid (eluent A---10:89:1, *v*/*v*/*v*; eluent B---97:2:1, *v*/*v*/*v*) containing 5 mM ammonium acetate. The total run time of one chromatographic run was 21 min: after an initial hold time of 2 min at 100 % A, 50 % B was reached within 3 min and 100 % B within the next 9 min. A hold time of 4.5 min at 100 % B was followed by 2.5 min at 100 % A for column re-equilibration. Before injecting the sample into the UHPLC system, the needle was washed in the flush port with acetonitrile/water (50:50, *v*/*v*) for 5 s.

Precursor and product ion selection and the optimisation of fragmentor voltages and collision energies were performed with flow injection of single-analyte solutions using MassHunter Optimizer Triple Quad B04.01. Optimisation was either done in one or in both ionisation modes depending on our experiences with previous methods. MassHunter Data Acquisition software version B04.01 was used to control the LC-MS/MS instrument. Analysis was carried out using electrospray ionisation (ESI) and the dynamic multiple reaction monitoring (DMRM) acquisition. DMRM allows the measurement of selected reaction monitoring transitions for a specified time period (expected retention time ± variable window width), hence resulting in maximized dwell times for each transition. Due to the amount of analytes and to ensure optimum ionisation yields, analysis was performed in two chromatographic runs---one for each ionisation mode. For each compound, two mass transitions were monitored (except for moniliformin and 3-nitropropionic acid), resulting in 4.0 identification points, which is in agreement with Commission Decision 2002/657/EC \[[@CR29]\]. The general source settings were as follows: gas temperature, 200 °C; gas flow, 8 L min^−1^; nebulizer, 40 psi (275.8 kPa); sheath gas temperature, 350 °C; sheath gas flow, 11 L min^−1^; capillary voltage, 3,500 V; and nozzle voltage, 500 V (positive) or 0 V (negative). Both scanning quadrupoles (MS1 and MS2) were set to unit resolution. Cycle time was set to 750 ms.

Method validation {#Sec6}
-----------------

For validation purposes, one blank sample of each commodity (almond, hazelnut, peanut and pistachio) was selected. For each matrix, four times 0.50 ± 0.01 g thoroughly homogenised and ground sample was weighed in 16-mL glass vials. Three of those samples were spiked on one medium concentration level by adding an aliquot of the multi-analyte stock solution prior to extraction. The samples were stored overnight at 40 °C in a Kelvirton® T60120 drying chamber (Heraeus Instruments, Hanau, Germany) to allow evaporation of the solvent. Thereafter, those three spiked samples as well as the fourth blank sample were processed according to the procedure described in "[Sample preparation](#Sec4){ref-type="sec"}". The remaining raw extract of the blank sample was used for the preparation of spiked raw extracts on seven levels without replicates and with relative concentrations of 1:3.33:10:33.3:100:333:1,000. This approach (adding the multi-analyte stock solution before and after extraction) allowed the direct determination of the apparent recovery (*R*~A~) as well as the assessment of matrix effects caused by signal suppression or enhancement (SSE) of the analyte signal.

Data evaluation {#Sec7}
---------------

For each analyte, linear, 1/*x* weighted calibration curves were calculated by plotting the peak area of the signal in neat standard solution versus the analyte concentration using MassHunter Quantitative Analysis. Apparent recoveries were calculated from the three samples spiked before extraction in the following way: In a first step, the ratio of the measured to spiked concentration for each of the three individual measurements was calculated and multiplied with 100. The average and standard deviation (SD) of those three values was the obtained *R*~A~ and SD for the respective analyte--matrix combination. Matrix effects (SSE) were determined in a similar way as the apparent recoveries, but in this case, the results from the raw extracts of the blank sample spiked on seven different concentration levels after extraction were used for the calculation. Hence, the ratio of the measured to the spiked concentration for these seven levels were calculated and multiplied with 100. For the calculation of the average SSE value, only those levels for which both the qualifier and the quantifier showed a distinct peak were used. The recovery of extraction was calculated by dividing the *R*~A~ value by the SSE value and a multiplication factor of 100. The lower limit of quantification (LLOQ) was calculated as follows: First, the concentration level of the raw extract spiked after extraction for which both mass transitions showed an S/N ratio above 10:1 was determined. This value was then multiplied with the dilution factor of 8 and corrected for the recovery of the extraction step of the respective matrix.

For positive results, the following criteria had to be fulfilled: First, the retention time had to be within ±2.5 % compared to the analyte in neat standard solution and both, the qualifier and the quantifier, transition had to be above an S/N ratio of 10:1. Furthermore, the ion ratio of the quantifier and the qualifier transition had to be within a defined target range according to Commission Decision 2002/657/EC \[[@CR29]\]. MassHunter Quantitative Analysis allows setting the criteria for retention time deviation as well as the ratio of quantifier and qualifier; non-compliance is marked in blue (lower) or red (higher) colour. All results obtained for the naturally contaminated samples were multiplied with the dilution factor of 8 and corrected with the apparent recoveries determined during the validation. For the calculation of the average values, all contaminated samples were taken into considerations; for values below the LLOQ, half of the LLOQ of the respective matrix was used.

Results and discussion {#Sec8}
======================

Development of the analytical method {#Sec9}
------------------------------------

Based on an HPLC-MS/MS multi-target method developed previously by our group \[[@CR4], [@CR7]\], a new UHPLC-MS/MS method was developed on an Agilent 1290 Infinity UHPLC system coupled to a 6460 Triple Quadrupole mass spectrometer. On purpose, we did not speed up the previous method, but used the employed stationary phase with sub-2-μm particles for better resolution of analytes from the matrix. The gradient was adapted from the original method and flattened to allow better separation of the analytes. Another major advantage of this method proved to be the use of the DMRM mode. Early multi-target methods for the determination of mycotoxins in food dealing with a large number of analytes (e.g. \[[@CR7]\]) employed time periods for which only certain analytes are measured to allow enough dwell time for each analyte. These periods are prone to retention time shifts due to various reasons, e.g. caused by slightly different solvent compositions, by declining column performances or slight temperature shifts. Using DMRM, the size of the retention time window for each mass transition can be set individually. As chromatographic conditions were very repeatable during method development, we generally set the time window to 1 min. Moreover, for broad chromatographic peaks (e.g. HC toxin and ustiloxin B), window widths of 2 min were used. If two analytes share the same mass transitions, window widths which includes the different retention times can be selected (e.g. 1.5 min for cytochalasin C and D or enniatin B2 and K1). Using these variable window widths, we obtained minimum dwell times of at least 10 ms, even in the most crowded sections of the chromatogram. In order to gain enough points over a given chromatographic peak, we set the duty cycle of the mass spectrometer to 750 ms. The usual peak showed a base width of 0.2 min, resulting in 16 data points, which were well suited for reliable integration of the peak area. Moreover, also cyclopiazonic acid, which is known to give broad peaks under acidic RP-HPLC conditions, showed an acceptable peak width of about 0.5 min in our case.

To ensure optimum sensitivity, we decided to apply two chromatographic runs per sample---one for each ionisation mode. For each analyte, the mode resulting in the most abundant signal was used and two mass transitions were selected: one for the use as quantifier and one as qualifier. The formation of sodium adducts of certain analytes led to insufficient fragment intensity because the positive charge remains on the sodium ion after collision-induced dissociation. Therefore, ammonium acetate was added to both of the solvents. Most analytes were detected as single-charged ions either as protonated \[M+H\]^+^ or ammonium adducts \[M + NH~4~\]^+^ (e.g. 4,15-diacetoxyscirpenol, enniatins and mycophenolic acid) in positive mode or as deprotonated \[M-H\]^−^ or acetate adducts \[M+OAc\]^−^ (e.g. the B-trichothecenes DON and nivalenol) in negative mode. Exceptions were cyclosporin A, C, D and H which were measured as doubly charged \[M+2H\]^2+^ ions. For alamethicin F30 (cleavage of the peptide bond) \[[@CR30]\] and also for fusarielin A (loss of water) in-source fragments were used as precursors as these ions were predominantly formed using ESI.

Table [1](#Tab1){ref-type="table"} summarises the obtained retention times, precursor and product ions including the optimised ESI-MS/MS settings for all analytes ionising in negative electrospray mode. The same parameters are given in Table [2](#Tab2){ref-type="table"} for the analytes showing higher ionisation abundance in positive electrospray mode. Only one fragment ion of sufficient sensitivity was obtained for the very small molecules moniliformin (98 g mol^−1^) and 3-nitropropionic acid (119 g mol^−1^). In general, the most abundant mass transition was used as the quantifier, but when the S/N ratio was significantly worse for this mass transition, another one was used. Using MassHunter Quantitative Analysis, the qualifier-to-quantifier ratios based on the peak area were calculated and non-compliant values according to Commission Decision 2002/657/EC \[[@CR29]\] were flagged automatically. Compared to a previously described method for the determination of 186 analytes including 164 fungal metabolites in dust \[[@CR30]\], we describe a method for the determination of a total number of 191 fungal metabolites which include all relevant mycotoxins. Bacterial metabolites, which can occur in house dust, were eliminated from the former method as those metabolites are not relevant for food.Table 1List of analytes determined in the negative ionisation mode and optimised ESI-MS/MS parametersAnalyte nameRetention time (min)*m*/*z* precursor ion (framentor voltage)Ion species*m*/*z* product ion (collision energy (V))3-Acetyldeoxynivalenol7.4397 (95)\[M+OAc\]^−^307 (8)/59 (20)alpha-Zearalenol11.8319 (195)\[M-H\]^−^160 (28)/130 (32)alpha-Zearalenol-14-glucoside9.2541 (100)\[M+OAc\]^−^319 (16)/481 (0)Alternariol10.4257 (190)\[M-H\]^−^213 (16)/215 (20)Alternariolmethylether12.5271 (170)\[M-H\]^−^256 (16)/227 (32)Altersolanol C7.8319 (105)\[M-H\]^−^283 (12)/301 (8)Altertoxin I10.0351 (140)\[M-H\]^−^315 (8)/263 (32)Apicidin13.0622 (220)\[M-H\]^−^462 (16)/252 (32)Atpenin A513.5364 (120)\[M-H\]^−^292 (4)/328 (0)beta-Zearalenol10.7319 (185)\[M-H\]^−^160 (28)/130 (32)beta-Zearalenol-14-glucoside8.1541 (115)\[M+OAc\]^−^319 (16)/481 (0)Cycloechinulin9.3350 (170)\[M-H\]^−^335 (20)/320 (28)Cyclopiazonic acid12.2335 (270)\[M-H\]^−^140 (28)/154 (32)Deoxynivalenol5.9355 (95)\[M+OAc\]^−^265 (8)/59 (16)Deoxynivalenol-3-glucoside5.8517 (145)\[M+OAc\]^−^427 (16)/457 (8)Emodin14.1269 (185)\[M-H\]^−^225 (20)/241 (20)Equisetin15.2372 (205)\[M-H\]^−^342 (20)/124 (48)Fusarenon-X6.6413 (110)\[M+OAc\]^−^263 (8)/59 (28)Fusidic acid15.1515 (190)\[M-H\]^−^221 (24)/455 (16)Macrosporin13.6283 (170)\[M-H\]^−^268 (16)/225 (36)Moniliformin1.597 (65)\[M-H\]^−^41 (8)Nidulin15.4441 (185)\[M-H\]^−^382 (20)/390 (24)3-Nitropropionic acid2.2118 (65)\[M-H\]^−^46 (8)Nivalenol4.8371 (110)\[M+OAc\]^−^281 (8)/59 (20)Nornidulin14.1427 (160)\[M-H\]^−^347 (16)/376 (20)Patulin4.5153 (70)\[M-H\]^−^109 (4)/81 (4)Penigequinolone A13.0466 (200)\[M-H\]^−^394 (32)/378 (48)Physcion15.4283 (145)\[M-H\]^−^240 (20)/211.6 (40)Pseurotin A8.6430 (100)\[M-H\]^−^270 (4)/308 (0)Radicicol9.0363 (165)\[M-H\]^−^183 (20)/224 (16)Rubellin D12.7541 (165)\[M-H\]^−^360 (24)/378 (16)Tentoxin10.4413 (160)\[M-H\]^−^271 (12)/141 (12)Tenuazonic acid8.4196 (150)\[M-H\]^−^112 (20)/139 (16)Zearalenone11.9317 (195)\[M-H\]^−^131 (28)/175 (20)Zearalenone-14-glucoside9.4479 (190)\[M-H\]^−^317 (8)/175 (44)Zearalenone-14-sulphate8.8397 (160)\[M-H\]^−^317 (20)/131 (44)Table 2List of analytes determined in the positive ionisation mode and optimised ESI-MS/MS parametersAnalyte nameRetention time (min)*m*/*z* precursor ion (framentor voltage)Ion species*m*/*z* product ion (collision energy (V))AAL toxin TA 19.0522 (165)\[M+H\]^+^328.5 (24)/292.4 (28)15-Acetyldeoxynivalenol7.4339 (110)\[M+H\]^+^321 (4)/137 (4)Aflatoxin B~1~8.7313 (165)\[M+H\]^+^285.2 (20)/128.1 (70)Aflatoxin B~2~8.4315 (190)\[M+H\]^+^287 (24)/259 (28)Aflatoxin G~1~8.0329 (175)\[M+H\]^+^200 (44)/243.2 (24)Aflatoxin G~2~7.7331 (190)\[M+H\]^+^313 (24)/245 (28)Aflatoxin M~1~7.7329 (180)\[M+H\]^+^273 (24)/229 (28)Aflatoxin M~2~7.3331 (145)\[M+H\]^+^273 (20)/285 (20)Agroclavine6.9239 (130)\[M+H\]^+^183 (16)/208 (16)Alamethicin F3014.9775 (225)\[y7^a^+H\]^+^282 (44)/197 (52)Altenuene8.6293 (100)\[M+H\]^+^257 (8)/275 (4)Altenusin8.8291 (90)\[M+H\]^+^128 (56)/199 (32)2-Amino-14,16-dimethyloctadecan-3-ol15.5314 (115)\[M+H\]^+^296.5 (16)/125 (12)Aspercolorin10.9465 (155)\[M+H\]^+^247 (16)/120 (48)Aspergillimide6.8360 (230)\[M+H\]^+^301 (36)/332 (12)Asperlactone5.6185 (65)\[M+H\]^+^141 (0)/113 (4)Asperloxin A10.1394 (205)\[M+H\]^+^123 (20)/95 (44)Aspinonene4.9206 (80)\[M+NH~4~\]^+^127 (0)/81 (12)Aspyrone6.2185 (75)\[M+H\]^+^125 (4)/139 (0)Asterric acid9.5349 (80)\[M+H\]^+^299 (8)/287 (12)Aureobasidin A15.81102 (270)\[M+H\]^+^665.5 (28)/210 (48)Austdiol6.5237 (125)\[M+H\]^+^117 (28)/159 (20)Austocystin A13.1373 (165)\[M+H\]^+^329 (28)/312 (28)Avenacein Y10.0319 (120)\[M+H\]^+^175 (36)/287 (16)Beauvericin15.0801.5 (180)\[M+NH~4~\]^+^244 (36)/262 (32)Brefeldin A10.2281 (75)\[M+H\]^+^245 (0)/199 (4)Brevicompanine B12.6368 (120)\[M+H\]^+^130 (24)/300 (8)Calphostin C13.9791 (220)\[M+H\]^+^485 (32)/515 (20)Cephalosporin C4.0416 (143)\[M+H\]^+^185 (12)/143 (12)Cerulenin9.7224 (85)\[M+H\]^+^196 (0)/179 (0)Chaetocin11.5697 (135)\[M+H\]^+^348 (12)/350 (12)Chaetoglobosin A12.3529 (135)\[M+H\]^+^130 (44)/511 (4)Chaetomin12.2711 (155)\[M+H\]^+^298 (12)/348 (8)Chanoclavine6.3257 (105)\[M+H\]^+^168 (16)/226 (8)Chlamydosporol7.1227 (110)\[M+H\]^+^167 (12)/106 (32)Citreoviridin A11.9420 (95)\[M+NH~4~\]^+^315.4 (0)/285 (8)Citrinin8.9251 (120)\[M+H\]^+^233 (12)/205 (28)Citromycetin8.7291 (115)\[M+H\]^+^245 (24)/217 (32)Cochliodinol16.0507 (150)\[M+H\]^+^371 (20)/439 (8)Curvularin9.7310 (75)\[M+NH~4~\]^+^125 (12)/169 (8)Cyclopenin8.5295 (105)\[M+H\]^+^146 (20)/177 (8)Cyclopeptine9.4281 (140)\[M+H\]^+^120 (20)/134 (20)Cyclosporin A+H^b^16.0602 (140)\[M+2H\]^2+^100 (56)/156 (32)Cyclosporin C15.4610 (125)\[M+2H\]^2+^100 (52)/156 (32)Cyclosporin D16.3609 (140)\[M+2H\]^2+^100 (52)/156 (32)Cytochalasin A12.7478 (190)\[M+H\]^+^91 (60)/120 (24)Cytochalasin B10.5480 (160)\[M+H\]^+^462.5 (12)/444.5 (12)Cytochalasin C11.2525 (110)\[M+NH~4~\]^+^430.5 (12)/490.5 (4)Cytochalasin D10.4525 (110)\[M+NH~4~\]^+^430.5 (12)/490.5 (4)Cytochalasin E11.6513 (110)\[M+NH~4~\]^+^434.5 (4)/416 (4)Cytochalasin H10.6494 (135)\[M+H\]^+^434.5 (4)/416.5 (8)Cytochalasin J9.8452 (145)\[M+H\]^+^434.5 (4)/416.5 (12)Decarestrictine D5.5217 (80)\[M+H\]^+^121 (8)/163 (4)Dechlorogriseofulvin9.1319 (135)\[M+H\]^+^181 (12)/251 (16)Deoxybrevianamid E10.1352 (110)\[M+H\]^+^130 (28)/284 (8)4,15-Diacetoxyscirpenol8.7384 (110)\[M+NH~4~\]^+^307 (4)/247 (8)Dihydroergine5.5270 (150)\[M+H\]^+^168 (28)/210 (20)Dihydroergosine8.3550 (190)\[M+H\]^+^270 (28)/253 (28)Dihydroergotamine8.5584 (190)\[M+H\]^+^270 (32)/254 (32)Dihydrolysergol6.0257 (160)\[M+H\]^+^167 (44)/154 (40)Elymoclavine5.9255 (135)\[M+H\]^+^181 (28)/180 (44)Elymoclavine-fructoside5.5417 (165)\[M+H\]^+^255 (16)/237 (20)Enniatin A15.5699 (170)\[M+NH~4~\]^+^210 (32)/228 (32)Enniatin A115.3685 (150)\[M+NH~4~\]^+^210 (32)/228 (32)Enniatin B14.7657 (160)\[M+NH~4~\]^+^196 (32)/214 (32)Enniatin B115.0672 (170)\[M+NH~4~\]^+^196 (32)/100 (60)Enniatin B214.1643 (145)\[M+NH~4~\]^+^196 (28)/214 (28)Enniatin B313.8629 (145)\[M+NH~4~\]^+^196 (28)/214 (28)Enniatin B414.7671.5 (170)\[M+NH~4~\]^+^196 (32)/100 (60)Enniatin K114.4643 (145)\[M+NH~4~\]^+^196 (28)/214 (28)Ergine+Erginine^b^5.5268 (125)\[M+H\]^+^223 (16)/208 (24)Ergocornine8.6562 (165)\[M+H\]^+^208 (48)/223 (36)Ergocorninine10.0562 (150)\[M+H\]^+^277 (24)/223 (36)Ergocristine9.3610 (140)\[M+H\]^+^592.5 (12)/223 (36)Ergocristinine11.0610 (140)\[M+H\]^+^592.5 (12)/223 (36)Ergocryptine9.3576 (155)\[M+H\]^+^208 (52)/223 (36)Ergocryptinine10.7576 (155)\[M+H\]^+^558.6 (12)/223 (36)Ergometrine5.9326 (145)\[M+H\]^+^223 (20)/208 (28)Ergometrinine6.5326 (145)\[M+H\]^+^223 (20)/208 (28)Ergosine8.2548 (165)\[M+H\]^+^223 (32)/208 (44)Ergosinine9.5548 (165)\[M+H\]^+^530.5 (12)/223 (32)Ergotamine+Ergotaminine^b^8.5582 (155)\[M+H\]^+^223 (32)/208 (48)Festuclavine7.0241 (160)\[M+H\]^+^154 (36)/168 (28)Fulvic acid7.6309 (115)\[M+H\]^+^231 (20)/161 (40)Fumagillin13.0459 (140)\[M+H\]^+^177 (8)/131 (24)Fumigaclavin A6.6299 (170)\[M+H\]^+^167 (48)/154 (44)Fumitremorgin C10.7380 (145)\[M+H\]^+^226 (16)/212 (32)Fumonisin B~1~10.3722.5 (210)\[M+H\]^+^352.3 (36)/334.4 (44)Fumonisin B~2~12.1706.3 (220)\[M+H\]^+^336.3 (40)/318.5 (40)Fumonisin B~3~11.3706.5 (220)\[M+H\]^+^336 (40)/318.5 (40)Fusaproliferin14.6445 (105)\[M+H\]^+^385 (4)/367 (4)Fusarielin A15.1385 (130)\[M-H~2~O+H\]^+^109 (16)/253 (8)Geodin11.4399 (125)\[M+H\]^+^340 (20)/355 (4)Gibberellic acid7.0364 (105)\[M+NH~4~\]^+^329 (4)/221 (24)Gliotoxin8.8327 (95)\[M+H\]^+^263 (4)/245 (16)Griseofulvin9.8353 (140)\[M+H\]^+^165 (16)/215 (16)HC toxin7.5437 (150)\[M+H\]^+^169 (28)/240 (16)HT-2 toxin10.0442.2 (100)\[M+NH~4~\]^+^263.1 (8)/215 (4)Hydrolysed fumonisin B~1~9.7406 (150)\[M+H\]^+^388 (12)/370 (16)16-Keto-aspergillimide13.1374 (185)\[M+H\]^+^313 (36)/315 (28)Kojic acid2.5143 (120)\[M+H\]^+^69 (16)/97 (12)Lysergol6.0255 (130)\[M+H\]^+^240 (20)/197 (20)Malformin C12.6530 (205)\[M+H\]^+^417 (12)/372 (16)Marcfortine A9.0478 (170)\[M+H\]^+^450 (16)/419 (32)Meleagrin8.8434 (140)\[M+H\]^+^403 (12)/334 (20)3-*O*-Methylsterigmatocystin11.0339 (160)\[M+H\]^+^306 (28)/324 (20)3-*O*-Methylviridicatin11.3252 (155)\[M+H\]^+^236 (28)/190 (48)Mevastatin13.9408 (95)\[M+NH~4~\]^+^185 (12)/271 (8)Mevinolin14.3422 (110)\[M+NH~4~\]^+^199 (4)/173 (24)15-Monoacetoxyscirpenol7.9342 (95)\[M+NH~4~\]^+^265 (0)/307 (4)Mycophenolic acid10.7338 (75)\[M+NH~4~\]^+^207 (28)/303 (8)Neosolaniol6.6400 (110)\[M+NH~4~\]^+^185 (16)/215 (12)Neoxaline8.4436 (130)\[M+H\]^+^405 (8)/263 (36)Ochratoxin A11.5404 (115)\[M+H\]^+^239 (20)/102 (70)Ochratoxin B10.3370 (115)\[M+H\]^+^205 (16)/103 (64)Ophiobolin A13.2401 (110)\[M+H\]^+^365 (4)/267 (8)Ophiobolin B13.8403 (105)\[M+H\]^+^367 (4)/349 (12)Oxaspirodione7.9251 (110)\[M+H\]^+^133 (16)/161 (4)Paraherquamide A8.4494 (160)\[M+H\]^+^419 (32)/176 (44)Paspalic acid5.5269 (140)\[M+H\]^+^182 (28)/167 (44)Paxilline14.1436 (120)\[M+H\]^+^182 (32)/167 (76)Penicillic acid6.6171 (70)\[M+H\]^+^125 (8)/97 (12)Penicillin G6.8335 (95)\[M+H\]^+^160 (4)/176 (8)Penitrem A13.9634 (165)\[M+H\]^+^558 (16)/616 (4)Pentoxyfylline7.3279 (130)\[M+H\]^+^181 (16)/99 (16)Pestalotin8.5215 (90)\[M+H\]^+^85 (12)/153 (8)Phomopsin A7.3789 (205)\[M+H\]^+^226 (40)/323 (24)Phomopsin B7.0755 (165)\[M+H\]^+^192 (40)/289 (24)Pyripyropene A11.6584 (260)\[M+H\]^+^148 (56)/202 (36)Roquefortine C10.2390 (145)\[M+H\]^+^193 (24)/322 (16)Roridin A11.2550 (120)\[M+NH~4~\]^+^249 (12)/231 (20)Rugulosin12.4543 (145)\[M+H\]^+^273 (20)/255 (36)Secalonic acid D13.3639 (220)\[M+H\]^+^561.4 (24)/589.4 (24)Setosusin10.5532 (160)\[M+NH~4~\]^+^413 (20)/299 (28)Sterigmatocystin12.3325 (160)\[M+H\]^+^281 (40)/130 (24)Sulochrin8.3333 (95)\[M+H\]^+^209 (4)/136 (48)T-2 tetraol4.8316 (95)\[M+NH~4~\]^+^215 (4)/281 (4)T-2 toxin10.9484.3 (120)\[M+NH~4~\]^+^185.1 (16)/215.2 (12)T-2 triol9.1400 (105)\[M+NH~4~\]^+^215 (4)/281 (0)Terphenyllin9.1339 (125)\[M+H\]^+^307 (8)/292 (20)Territrem B11.7527 (205)\[M+H\]^+^291 (28)/491 (20)Trichodermin11.1293 (100)\[M+H\]^+^109 (16)/143 (12)Tryprostatin A10.2382 (115)\[M+H\]^+^326 (8)/228 (12)Ustiloxin A5.5674 (220)\[M+H\]^+^187 (32)/209 (36)Ustiloxin B4.7646.2 (170)\[M+H\]^+^181 (36)/187 (28)Ustiloxin D5.7495 (135)\[M+H\]^+^192 (20)/291 (12)Verrucarin A10.9520 (125)\[M+NH~4~\]^+^249 (12)/457 (8)Verrucofortine11.9410 (150)\[M+H\]^+^130 (32)/300 (16)Verruculogen12.8512 (125)\[M+H\]^+^352 (16)/494 (0)Viomellein12.5561 (215)\[M+H\]^+^530 (28)/511 (32)Viridicatin11.2238 (155)\[M+H\]^+^165 (36)/192 (24)Wortmannin8.8429 (95)\[M+H\]^+^355 (4)/295 (20)^a^In-source fragment obtained from the cleavage of the corresponding peptide bond^b^Due to co-elution and the same DMRM transitions, these analytes cannot be distinguished

Method performance parameters {#Sec10}
-----------------------------

Method performance parameters were obtained by spiking blank samples before extraction on one medium level in triplicate and the raw extract of a blank sample after extraction on seven levels without replicates. It has to be pointed out that only 0.5 g of highly homogenised blank nuts was used for validation purposes to minimise the amount of spiked toxins. The results are presented in Tables [3](#Tab3){ref-type="table"}, [4](#Tab4){ref-type="table"}, [5](#Tab5){ref-type="table"} and [6](#Tab6){ref-type="table"} for almonds, hazelnuts, peanuts and pistachios, respectively. Spiking was performed with the whole multi-analyte mix containing all metabolites, but data evaluation was restricted to the most important analytes, e.g. detected in the naturally contaminated nut samples, regulated mycotoxins or mycotoxins frequently found in other commodities. In total, method performance parameters for 65 analytes are shown and are discussed in the following. For about half of the analytes, apparent recoveries between 80 and 120 % were achieved. This number was expected since a multi-target method covering a huge number of chemically diverse analytes always has to be a compromise. The chosen extraction solvent, as well as chromatographic conditions (regarding separation from matrix), was a compromise to include all analytes into the method. For example, in the case of ergot alkaloids, epimerisation is favoured under the used acidic conditions and, hence, only a rough estimate of a sum concentration is possible \[[@CR31]\]. For the determination of specific analytes at a very high level of sensitivity, more dedicated methods (validated for the respective matrix) are recommended. These methods often also allow sample concentration as cleanup procedures can be employed. For the accurate determination of regulated mycotoxins, the use of stable isotope-labelled internal standards is also an excellent option. For instance, deuterated AFB~2~ and AFG~2~ had been used for the quantification of aflatoxins in almonds \[[@CR32]\] or 11 U-\[^13^C\]-labelled mycotoxins were applied in the analysis of maize \[[@CR33]\].Table 3Method performance characteristics determined for almondsAnalyteLLOQ (μg kg^−1^)*R* ~A~ (%) ± SD^a^SSE (%)^b^*R* ~E~ (%)^c^3-Acetyldeoxynivalenol4851 ± 2245112Aflatoxin B~1~3.0101 ± 687115Aflatoxin B~2~1081 ± 1081100Aflatoxin G~1~1078 ± 178101Aflatoxin G~2~8.285 ± 167127Aflatoxin M~1~7.973 ± 370104Alamethicin F3019033 ± 58838alpha-Zearalenol16125 ± 713791alpha-Zearalenol-14-glucoside11098 ± 1012678Alternariol3.0115 ± 512691Alternariolmethylether0.8117 ± 7108109Altertoxin I1395 ± 410491Apidicin0.798 ± 411784Atpenin A51.3124 ± 8123101Beauvericin0.286 ± 885102beta-Zearalenol15143 ± 214598beta-Zearalenol-14-glucoside9968 ± 57987Chaetocin11029 ± 112623Chlamydosporol53101 ± 478129Curvularin31107 ± 10105101Cycloechinulin1.0195 ± 12187104Cyclopiazonic acid60124 ± 1316675Cyclosporin A+H2966 ± 47095Cytochalasin J2596 ± 694101Deoxynivalenol47022 ± 4191164,15-Diacetoxyscirpenol16104 ± 892114Emodin3.4120 ± 915080Enniatin A2.4106 ± 2381132Enniatin A12.076 ± 187799Enniatin B0.1100 ± 1110793Enniatin B10.284 ± 883102Enniatin B20.7107 ± 1199108Enniatin B30.05108 ± 896113Enniatin B40.188 ± 89989Enniatin K10.395 ± 59798Equisetin17222 ± 1128578Fumonisin B~1~16041 ± 410042Fumonisin B~2~18038 ± 79639HC toxin13035 ± 95860HT-2 toxin46113 ± 895119Kojic acid23034 ± 23889Macrosporin2.7165 ± 20146113Meleagrin21104 ± 9951093-*O*-Methylsterigmatocystin2.099 ± 597102Moniliformin5.115 ± 11788Mycophenolic acid24101 ± 894107Neoxaline3.093 ± 710390Nidulin0.573 ± 399743-Nitropropionic acid5.845 ± 44698Nivalenol4414 ± 312123Nornidulin1.2111 ± 812588Ochratoxin A1590 ± 889101Ochratoxin B9.984 ± 59489Penigequinolone A0.4142 ± 1415095Pestalotin6.0112 ± 1198114Physcion260155 ± 1329353Pseurotin A25159 ± 1217392Roquefortine C5.5136 ± 797141Secalonic acid D4177 ± 59978Sterigmatocystin2.8106 ± 710898T-2 toxin5.2105 ± 9101104Tentoxin1.2111 ± 412092Viridicatin7.5104 ± 7100104Zearalenone5.3127 ± 6122104Zearalenone-14-sulphate5.262 ± 68672*LLOQ* lower limit of quantification^a^Apparent recovery and standard deviation thereof (triplicate analysis on medium level)^b^Mean value for the signal suppression or enhancement calculated from up to seven concentration levels without replicates^c^Calculated extraction recovery (*R* ~A~/SSE × 100)Table 4Method performance characteristics determined for hazelnutsAnalyteLLOQ (μg kg^−1^)*R* ~A~ (%) ± SD^a^SSE (%)^b^*R* ~E~ (%)^c^3-Acetyldeoxynivalenol5455 ± 655100Aflatoxin B~1~1097 ± 139899Aflatoxin B~2~1187 ± 59097Aflatoxin G~1~4.481 ± 610379Aflatoxin G~2~1183 ± 88993Aflatoxin M~1~9.868 ± 78184Alamethicin F3021031 ± 79035alpha-Zearalenol1899 ± 1212281alpha-Zearalenol-14-glucoside49071 ± 912158Alternariol3.095 ± 710789Alternariolmethylether2.995 ± 710194Altertoxin I1490 ± 510685Apidicin0.877 ± 911369Atpenin A51.6104 ± 1012782Beauvericin0.677 ± 38987beta-Zearalenol16106 ± 811889beta-Zearalenol-14-glucoside17064 ± 612751Chaetocin18023 ± 115814Chlamydosporol69107 ± 3107100Curvularin3397 ± 310593Cycloechinulin3.6132 ± 1313896Cyclopiazonic acid56121 ± 2314981Cyclosporin A+H3657 ± 77378Cytochalasin J3477 ± 410176Deoxynivalenol4640 ± 8341184,15-Diacetoxyscirpenol1997 ± 610196Emodin3.999 ± 914370Enniatin A3.073 ± 2072102Enniatin A10.583 ± 673114Enniatin B0.199 ± 810495Enniatin B10.278 ± 78295Enniatin B21.082 ± 710579Enniatin B30.192 ± 610092Enniatin B40.175 ± 110472Enniatin K10.574 ± 210769Equisetin17188 ± 1524278Fumonisin B~1~19037 ± 510535Fumonisin B~2~24031 ± 310929HC toxin50031 ± 76151HT-2 toxin5994 ± 710093Kojic acid28034 ± 34773Macrosporin3.2146 ± 2515098Meleagrin1995 ± 4791203-*O*-Methylsterigmatocystin2.489 ± 310386Moniliformin5.314 ± 11784Mycophenolic acid2793 ± 610092Neoxaline3.597 ± 1012876Nidulin0.661 ± 4103603-Nitropropionic acid7.136 ± 24579Nivalenol8616 ± 12663Nornidulin0.593 ± 1214365Ochratoxin A1873 ± 79280Ochratoxin B1467 ± 310862Penigequinolone A0.5116 ± 2015774Pestalotin6.2109 ± 398111Physcion270129 ± 625251Pseurotin A3.0111 ± 1914378Roquefortine C6.0119 ± 993128Secalonic acid D4969 ± 1010665Sterigmatocystin3.187 ± 39988T-2 toxin5.690 ± 79396Tentoxin1.293 ± 1210787Viridicatin8.396 ± 510394Zearalenone2.291 ± 711182Zearalenone-14-sulphate7.847 ± 510047*LLOQ* lower limit of quantification^a^Apparent recovery and standard deviation thereof (triplicate analysis on medium level)^b^Mean value for the signal suppression or enhancement calculated from up to seven concentration levels without replicates^c^Calculated extraction recovery (*R* ~A~/SSE × 100)Table 5Method performance characteristics determined for peanutsAnalyteLLOQ (μg kg^−1^)R~A~ (%) ± SD^a^SSE (%)^b^*R* ~E~ (%)^c^3-Acetyldeoxynivalenol19017 ± 11796Aflatoxin B~1~1084 ± 98599Aflatoxin B~2~1084 ± 482103Aflatoxin G~1~1267 ± 57588Aflatoxin G~2~9.473 ± 466111Aflatoxin M~1~8.765 ± 36995Alamethicin F3011063 ± 49169alpha-Zearalenol14107 ± 210899alpha-Zearalenol-14-glucoside97104 ± 211788Alternariol8.8101 ± 398102Alternariolmethylether2.784 ± 184101Altertoxin I1479 ± 28790Apidicin0.697 ± 310791Atpenin A51.2132 ± 3126105Beauvericin0.494 ± 882115beta-Zearalenol15115 ± 211997beta-Zearalenol-14-glucoside9946 ± 25487Chaetocin12024 ± 111421Chlamydosporol16125 ± 997129Curvularin29107 ± 4100107Cycloechinulin3.1148 ± 5135110Cyclopiazonic acid6184 ± 211474Cyclosporin A+H2864 ± 86499Cytochalasin J2692 ± 492101Deoxynivalenol15029 ± 1241204,15-Diacetoxyscirpenol1892 ± 491100Emodin11122 ± 615181Enniatin A2.886 ± 1779110Enniatin A11.4101 ± 3772141Enniatin B0.05117 ± 1681144Enniatin B10.1102 ± 889114Enniatin B22.495 ± 1187109Enniatin B30.04100 ± 379126Enniatin B40.297 ± 492106Enniatin K10.398 ± 888111Equisetin13267 ± 1327697Fumonisin B~1~21033 ± 810233Fumonisin B~2~18040 ± 310538HC toxin13018 ± 13058HT-2 toxin5099 ± 890110Kojic acid28027 ± 13774Macrosporin2.6166 ± 6137121Meleagrin16107 ± 2731463-*O*-Methylsterigmatocystin1.988 ± 282106Moniliformin6.316 ± 12372Mycophenolic acid2684 ± 38797Neoxaline2.8113 ± 411995Nidulin0.575 ± 198763-Nitropropionic acid6.951 ± 16282Nivalenol6919 ± 12578Nornidulin1.2118 ± 113786Ochratoxin A1778 ± 38988Ochratoxin B3777 ± 59680Penigequinolone A1.0146 ± 5139105Pestalotin6.2101 ± 591111Physcion260161 ± 1229554Pseurotin A23152 ± 9150102Roquefortine C5.294 ± 563149Secalonic acid D38105 ± 512584Sterigmatocystin2.497 ± 384115T-2 toxin5.194 ± 788107Tentoxin1.1108 ± 511593Viridicatin7.895 ± 296100Zearalenone5.7109 ± 111297Zearalenone-14-sulphate5.265 ± 29469*LLOQ* lower limit of quantification^a^Apparent recovery and standard deviation thereof (triplicate analysis on medium level)^b^Mean value for the signal suppression or enhancement calculated from up to seven concentration levels without replicates^c^Calculated extraction recovery (*R* ~A~/SSE × 100)Table 6Method performance characteristics determined for pistachiosAnalyteLLOQ (μg kg^−1^)*R* ~A~ (%) ± SD^a^SSE (%)^b^*R* ~E~ (%)^c^3-Acetyldeoxynivalenol4537 ± 531120Aflatoxin B~1~1085 ± 683102Aflatoxin B~2~1142 ± 34396Aflatoxin G~1~1069 ± 669100Aflatoxin G~2~1162 ± 116497Aflatoxin M~1~8.960 ± 66593Alamethicin F3024328 ± 39430alpha-Zearalenol17100 ± 211785alpha-Zearalenol-14-glucoside10067 ± 58083Alternariol9.697 ± 110294Alternariolmethylether0.9107 ± 2107100Altertoxin I1491 ± 210190Apidicin0.782 ± 211074Atpenin A51.4121 ± 313192Beauvericin0.672 ± 107892beta-Zearalenol15119 ± 712695beta-Zearalenol-14-glucoside12072 ± 19774Chaetocin26033 ± 111229Chlamydosporol20083 ± 382101Curvularin100100 ± 8100100Cycloechinulin1.1129 ± 713496Cyclopiazonic acid58131 ± 616878Cyclosporin A+H3659 ± 17579Cytochalasin J2885 ± 89193Deoxynivalenol24118 ± 482254,15-Diacetoxyscirpenol5.492 ± 491102Emodin3.5114 ± 214777Enniatin A2.595 ± 1376126Enniatin A12.365 ± 47784Enniatin B0.1105 ± 3793114Enniatin B10.283 ± 1179104Enniatin B20.880 ± 28891Enniatin B30.190 ± 19792Enniatin B40.183 ± 29984Enniatin K10.389 ± 1887102Equisetin15193 ± 723184Fumonisin B~1~20037 ± 110734Fumonisin B~2~22034 ± 311031HC toxin ^d^HT-2 toxin5596 ± 796100Kojic acid23028 ± 13290Macrosporin3.1172 ± 17171101Meleagrin1980 ± 2671203-*O*-Methylsterigmatocystin7.491 ± 39893Moniliformin1716 ± 11980Mycophenolic acid2692 ± 49597Neoxaline^d^Nidulin1.662 ± 298633-Nitropropionic acid1939 ± 14487Nivalenol956 ± 23189Nornidulin1.4105 ± 314174Ochratoxin A1879 ± 39484Ochratoxin B1075 ± 18687Penigequinolone A1.3132 ± 416282Pestalotin6.993 ± 39399Physcion76150 ± 624661Pseurotin A28156 ± 1318584Roquefortine C5.6111 ± 181137Secalonic acid D4873 ± 511067Sterigmatocystin2.793 ± 59499T-2 toxin5.595 ± 59798Tentoxin1.1101 ± 210894Viridicatin8.094 ± 0.29797Zearalenone6.1104 ± 211789Zearalenone-14-sulphate5.667 ± 59769*LLOQ* lower limit of quantification^a^Apparent recovery and standard deviation thereof (triplicate analysis on medium level)^b^Mean value for the signal suppression or enhancement calculated from up to seven concentration levels without replicates^c^Calculated extraction recovery (*R* ~A~/SSE × 100)^d^Due to interferences, it was not possible to evaluate HC toxin and neoxaline in pistachios

In our case, the obtained standard deviation of *R*~A~ was below 10 % for the vast majority of the analyte--matrix combinations. In only 6 % of the cases were values above 15 % determined, e.g. for enniatin A (13--23 %) and macrosporin (6--25 %). Significant deviations from 100 % apparent recovery were either caused by severe matrix effects or insufficient extraction. Fifty-seven per cent of the analyte--matrix combinations showed SSE values between 80 and 120 %. Suppression of the analyte signal to more than the half compared to the neat standard was observed for early-eluting analytes 3-nitropropionic acid, moniliformin, kojic acid, as well as for the B-trichothecenes (nivalenol, DON and 3-acetyldeoxynivalenol) in all four matrices. Significant signal enhancement of more than 120 % was observed for up to 17 analytes (almonds). The highest values were observed for physcion (246--295 %) and equisetin (231--285 %). Interestingly, for β-zearalenol-14-glucoside, a signal suppression to 54 and 79 % for peanuts and almonds, respectively, were determined, whereas no matrix effect was monitored for pistachios (97 %) and a significant signal enhancement of 127 % was observed in hazelnuts. This emphasises the importance of proper validation and indicates that samples belonging to the same food category can still show quite different matrix effects. The used solvent (acetonitrile/water/acetic acid (79:20:1, *v*/*v*/*v*) was well suited for the extraction of almost all analysed mycotoxins from the four different commodities. Ninety-four per cent of the analyte--matrix combinations showed extraction recoveries higher than 50 %. Lower *R*~E~ values were for example observed for fumonisins (29 and 42 %), which were even lower than reported before for wheat (43--53 %) and maize (57--67 %) using the same solvent mixture for extraction \[[@CR4]\]. In cases of severe matrix suppression, e.g. SSE of 8 % for DON in pistachios, also unreliable *R*~E~ values were calculated (e.g. 225 % for DON in pistachios).

The linear range covered two orders of magnitude in most cases. For atpenin A5, even a linear range of three orders of magnitude was observed in all four matrices. The LLOQs varied between sub-microgram per kilogram levels, e.g. for apicidin, beauvericin and enniatins, and up to 500 μg kg^−1^ for HC toxin in hazelnuts. It should be pointed out here that in some cases (e.g. altertoxin I, atpenin A5 or neoxaline), even the lowest spiking level showed an S/N ratio above 10. All shown LLOQs will undoubtedly be higher compared to calculations based on S/N ratios equalling 10. We decided on purpose for this very conservative calculation of the LLOQs to minimize the influence of day-to-day performance differences, which are often encountered in mass spectrometry due to staining of the ion path. Still, the obtained recoveries and LLOQs were in a similar range as those reported before for peanuts \[[@CR28]\], with the exception of DON due to signal suppression in our case. However, the gained standard deviations were lower in our proposed method, which can be partly explained by the combination of three different blank materials by Warth and co-workers, whereas we used one blank material and spiked it in triplicate. In comparison to \[[@CR5]\], both for peanuts and pistachios, our method proved to be more repeatable for almost all analytes. The limits of detection were significantly lower for aflatoxins, OTA and fumonisins in the method proposed by Spanjer et al. \[[@CR5]\], whilst they were lower for, e.g. zearalenone and T-2 toxin in our method. Compared to our method, lesser matrix effects were obtained by Ediage et al. \[[@CR27]\] after extensive cleanup for 25 mycotoxins.

The gained LLOQs for aflatoxins are higher than the maximum levels set in Commission Regulation (EC) No. 1881/2006 and its amendments \[[@CR3]\], rendering this method unsuited for regulatory purposes. Still, the presented method can be an appropriate supplement to already existing single-analyte or analyte-group detection methods which usually have been developed specifically for the respective target analytes in certain matrices. Alternatives to gain the needed sensitivity are cleanup and enrichment of aflatoxins (e.g. by immunoaffinity columns), a method parameter set which is optimised on those compounds, or the use of a more sensitive mass spectrometer \[[@CR33]\]. Finally, albeit the method was validated for nuts, it is also applicable for the screening of mycotoxins in several other food and feed.

Naturally contaminated nut samples {#Sec11}
----------------------------------

Information about the occurrence of other mycotoxins than aflatoxins and OTA in nuts is very limited in the literature. We were able to show the applicability of the method through the analysis of 53 different nut (8 almonds, 22 hazelnuts, 15 peanuts and 8 pistachios) samples. Further microbial investigations about the source and time point of contamination are warranted and the scope of future experiments. Figure [1](#Fig1){ref-type="fig"} provides an overview of the detected mycotoxins in the analysed samples and presents the percentage of contaminated nut samples compared to all analysed samples of the respective analyte. In Table [7](#Tab7){ref-type="table"}, more detailed information including the average concentration of contaminated samples and the maximum observed level is given. In total, the presence of 40 analytes could be confirmed in different kinds of nuts. Most analytes were determined in hazelnuts (36), followed by peanuts (30), almonds (13) and pistachios (5). The reported mycotoxins are produced by a wide range of food spoilage and contaminating fungal species, including *Aspergillus* spp. (e.g. aflatoxins, sterigmatocystin); *Fusarium* spp. (e.g. ennitatins, equisetin); *Penicillium* spp. (e.g. mycophenolic acid, roquefortine C); and *Alternaria* spp. (e.g. alternariol, macrosporin). The most prevalent mycotoxin was beauvericin, which was identified in 42 samples, followed by enniatin B (33), macrosporin (30) and 3-nitropropionic acid (29). Beauvericin is a depsipeptide produced by various *Fusarium* spp.; concentrations up to 31 μg kg^−1^ in hazelnuts and 12 μg kg^−1^ in peanuts were observed. These values are in very good accordance to the occurrence of beauvericin in peanuts (0.1--24.0 μg kg^−1^, 73 % positive samples) reported before \[[@CR28]\]. The contamination range was higher than reported by \[[@CR26]\] in peanut cake (0.05--3.36 μg kg^−1^). Furthermore, several *Alternaria* mycotoxins were found in nuts, with alternariolmethylether (27 samples), alternariol (24 samples) and tentoxin (22 samples) being the most prevalent. Also tenuazonic acid was detected in 21 samples, with apparently high concentration, although this analyte was not part of the validated compounds. Emodin was found in 28 out of 53 samples, which is in agreement with the occurrence of this *Aspergillus* mycotoxin reported previously in inoculated peanuts \[[@CR34]\]. In one hazelnut sample, 26 analytes were determined, and eight other hazelnut samples were contaminated with 20 or more mycotoxins. In peanuts, almonds and pistachios, up to 17, 13 and 5 analytes, respectively, were detected in one sample.Fig. 1Overview of the detected mycotoxins in the analysed samplesTable 7Mycotoxin contamination of analysed nut samplesAnalyteAlmonds (*n* = 8)Hazelnuts (*n* = 22)Peanuts (*n* = 15)Pistachios (*n* = 8)Avg.^a^ (μg kg^−1^)Max.^b^ (μg kg^−1^)Avg.^a^ (μg kg^−1^)Max.^b^ (μg kg^−1^)Avg.^a^ (μg kg^−1^)Max.^b^ (μg kg^−1^)Avg.^a^ (μg kg^−1^)Max.^b^ (μg kg^−1^)Aflatoxin B~1~--n.d.7.4 (10)1568 (8)230--n.d.Aflatoxin B~2~--n.d.5.5 (4)\<LLOQ11 (8)22--n.d.Aflatoxin G~1~--n.d.16 (12)28--n.d.--n.d.Aflatoxin G~2~--n.d.5.5 (8)\<LLOQ--n.d.--n.d.Alamethicin F30--n.d.110 (9)\<LLOQ--n.d.--n.d.Alternariol1.5 (1)\<LLOQ78 (20)6504.4 (3)\<LLOQ--n.d.Alternariolmethylether0.56 (3)0.8459 (19)2201.4 (5)\<LLOQ--n.d.Altertoxin I--n.d.7.0 (2)\<LLOQ--\<LLOQ--n.d.Apicidin--n.d.3.4 (6)14--\<LLOQ--n.d.Atpenin A5--n.d.--n.d.--\<LLOQ--n.d.Beauvericin0.10 (8)\<LLOQ2.4 (18)311.6 (15)120.30 (1)\<LLOQCurvularin--n.d.19 (9)4219 (2)24--n.d.Cyclopiazonic acid64 (3)130--n.d.140 (4)310--n.d.Emodin1.7 (2)\<LLOQ5.5 (16)235.5 (10)\<LLOQ--n.d.Enniatin A--n.d.28 (8)1701.4 (3)\<LLOQ--n.d.Enniatin A1--n.d.140 (9)1,1000.70 (5)\<LLOQ--n.d.Enniatin B0.05 (8)\<LLOQ37 (17)5400.23 (8)0.45--n.d.Enniatin B10.12 (6)0.21--n.d.--n.d.--n.d.Enniatin B2--n.d.3.0 (5)8.9--n.d.--n.d.Enniatin B30.05 (1)0.050.06 (5)0.11--n.d.--n.d.Enniatin B4--n.d.22 (10)1900.1 (5)\<LLOQ--n.d.Equisetin8.5 (2)\<LLOQ110 (2)20014 (6)41--n.d.HT-2 toxin--n.d.39 (15)130--n.d.--n.d.Kojic acid--n.d.1,100 (10)1,4008,900 (6)40,000--n.d.Macrosporin2.1 (4)4.4280 (20)2,2009.4 (3)264.6 (3)113-*O*-Methyl-sterigmatocystin--n.d.1.7 (10)3.91.6 (5)2.7--n.d.Moniliformin--n.d.5.8 (7)9.2--n.d.--n.d.Mycophenolic acid--n.d.700 (18)6,10021 (6)6013 (1)\<LLOQ3-Nitropropionic acid--n.d.440 (22)98082 (7)350--n.d.Ochratoxin A--n.d.220 (1)22067 (6)2609.0 (1)\<LLOQOchratoxin B--n.d.6.9 (1)6.931 (5)82--n.d.Pestalotin--n.d.3.1 (12)\<LLOQ5.4 (8)21--n.d.Physcion--n.d.700 (16)3,300--\<LLOQ--n.d.Secalonic acid D31 (3)51--n.d.--n.d.--n.d.Sterigmatocystin--n.d.2.3 (21)5.51.2 (5)\<LLOQ--n.d.T-2 toxin--n.d.32 (15)40--n.d.--n.d.Tentoxin0.60 (1)\<LLOQ5.4 (17)214.7 (4)11--n.d.Viridicatin3.8 (4)\<LLOQ5.7 (7)153.9 (6)\<LLOQ4.0 (6)\<LLOQZearalenone--n.d.7.6 (4)212.9 (2)\<LLOQ--n.d.Zearalenone-14-sulphate--n.d.3.9 (1)\<LLOQ2.6 (1)\<LLOQ--n.d.*n* total number of samples analysed in this category, *n*.*d*. not detected, \<*LLOQ* below the lower limit of quantification^a^Average of samples with detectable amounts of the specific analyte; in parentheses, the number of samples used for the calculation is given (in the case of detectable levels which are below the LLOQ, half of the LLOQ of the respective matrix was used for calculation)^b^Highest determined concentration

Almond and especially pistachio samples were contaminated to a lesser extent than peanut and hazelnut samples. However, it has to be kept in mind that the sample size was also smaller for those matrices. In the case of pistachios, only five analytes could be determined and only one sample was contaminated above the LLOQ (11 μg kg^−1^ macrosporin). Concerning almonds, 15 analytes were determined, among others *Alternaria* toxins and enniatins. The highest contamination was observed for cyclopiazonic acid (up to 130 μg kg^−1^) and secalonic acid D (up to 51 μg kg^−1^).

Some hazelnut samples showed significant contamination, including aflatoxins (up to 15 μg kg^−1^ AFB~1~ and 28 μg kg^−1^ AFG~1~) and *Alternaria* mycotoxins (up to 650 μg kg^−1^ alternariol and 220 μg kg^−1^ alternariolmethylether). The determined AFB~1~ concentrations were above the maximum level set in the European Union (2.0/5.0/8.0/8.0 μg kg^−1^ AFB~1~ in peanuts, hazelnuts, almonds and pistachios, respectively) \[[@CR3]\] for eight hazelnut and eight peanut samples. 3-Nitropropionic acid (up to 980 μg kg^−1^) was determined in all hazelnut samples. Sterigmatocystin (up to 5.5 μg kg^−1^), the most toxic AFB~1~ precursor, was found in 21 out of the 22 analysed hazelnut samples. We were also able to identify T-2 and HT-2 toxins in nut samples for the first time ever. Whereas the occurrence of these toxins was never confirmed in nuts, several *Fusarium* spp. including the T-2- and HT-2-producing *Fusarium oxysporum* were detected on almonds and pistachios before \[[@CR35]\]. Average values of the contaminated 15 samples were 39 and 32 μg kg^−1^ for the HT-2 and T-2 toxins, respectively. In 17 hazelnut samples, enniatin B was detected reaching levels up to 540 μg kg^−1^. The highest concentration of all enniatins was about 1100 μg kg^−1^ in a single hazelnut sample, whilst in no other commodity were enniatins found above 0.5 μg kg^−1^. With regard to mycophenolic acid, a potent immunosuppressive compound, one sample was contaminated with 6,100 μg kg^−1^. In addition, macrosporin was found up to 2,200 μg kg^−1^.

In peanuts, 32 analytes were detected. The highest contamination was observed for a sample containing 40 mg kg^−1^ kojic acid; the most prevalent was beauvericin, which was detected in all samples with an average concentration of 1.6 μg kg^−1^ and a maximum of 12 μg kg^−1^. As already pointed out in \[[@CR28], [@CR36]\], we could confirm the presence of cyclopiazonic acid, a mycotoxin produced, e.g. by *Aspergillus flavus*, in four peanut samples up to a concentration of 310 μg kg^−1^. This is a lower contamination rate as reported before \[[@CR28], [@CR36]\]. Also, for 3-nitropropionic acid, previously determined concentrations \[[@CR28]\] have been verified.

Conclusion {#Sec12}
==========

In conclusion, an UHPLC-MS/MS-based method for the determination of 191 mycotoxins and other fungal metabolites has been developed. Compared to other LC-MS/MS methods, UHPLC allowed better separation of the analytes from the matrix. Whilst most methods for the determination of mycotoxins focus on cereals or cereal-based foods, we developed a method for almonds, hazelnuts, peanuts and pistachios. An in-house validation for 65 analytes was performed, allowing the quantification of those analytes in the four commodities. For the other 126 analytes, the method still can provide semiquantitative information about the degree of contamination, and additional analytes might be validated afterwards, if needed. The overall repeatability of the proposed method is superior to currently published methods.

The method is based on a fast and easy sample preparation, including a single extraction step and subsequent injection of the diluted raw extract into the UHPLC-MS/MS system without any sample cleanup. Two chromatographic runs for each sample allow a throughput of about 25 samples per day (including standards). As with all multi-target methods, the major bottleneck regarding sample throughput is data evaluation, which is quite laborious and time-consuming. Various software tools, in particular "compound at a glance" or flagging options, can greatly assist in this process, though.

Finally, the method has been applied to the analysis of 53 different nut samples. In total, 40 different analytes were detected, showing the importance of multi-mycotoxin methods. It seems that besides aflatoxins, the only mycotoxins regulated in nuts in the European Union, other toxins might also be relevant. The obtained mycotoxin pattern shows that a variety of fungal species, including *Aspergillus* spp., *Penicillium* spp., *Fusarium* spp. and *Alternaria* spp., might grow on nuts and are capable of producing a variety of toxins. The most prominent mycotoxins found in more than 50 % of the samples were beauvericin, ennitatin B, macrosporin, 3-nitropropionic acid, emodin and alternariolmethylether. Additionally, we could, for the first time, confirm the presence of HT-2 and T-2 toxin in hazelnuts. For many of the detected mycotoxins, possible toxic effects on humans are still not fully evaluated. Even more, possible additive or synergistic effects of co-occurring toxins are largely unknown. The major benefit of the developed method is its usage in the (semi-)quantitative screening for a large number of mycotoxins and other fungal metabolites in nuts and food in general.
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